Abstract:Michaela Vojnikova, 1, 2, &ast Martina Sukupova, 1, 3, &ast Michal Stefanik, 1, 4 Petra Strakova, 3– 5 Jan Haviernik, 4 Katerina Kapolkova, 1 Eliska Gruberova, 1 Klara Raskova, 1 Hana Michalkova, 1 Pavel Svec, 1 Marie Peskova Kudlickova, 1 Ivana Huvarova, 4 Daniel Ruzek, 3– 5 Jiri Salat, 3– 5 Vladimir Pekarik, 1 Ludek Eyer, 3– 5 Zbynek Heger 1 1 Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic; 2 Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic; 3 Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic; 4 Department of infectious Diseases and Preventive Medicine, Veterinary Research Institute, Brno, Czech Republic; 5 Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic &astThese authors contributed equally to this work Correspondence: Zbynek Heger, Research Group for Molecular Biology and Nanomedicine, Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, CZ-613 00, Czech Republic, Tel +420-5-4513-3350, Fax +420-5-4521-2044, Email Background: As highlighted by recent pandemic outbreaks, antiviral drugs are crucial resources in the global battle against viral diseases. Unfortunately, most antiviral drugs are characterized by a plethora of side effects and low efficiency/poor bioavailability owing to their insolubility. This also applies to the arylnaphthalide lignin family member, diphyllin (Diph). Diph acts as a vacuolar ATPase inhibitor and has been previously identified as a promising candidate with broad-spectrum antiviral activity. However, its physicochemical properties preclude its efficient administration in vivo, complicating preclinical testing. Methods: We produced human recombinant H - ferritin (HsaFtH) and used it as a delivery vehicle for Diph encapsulation through pH-mediated reversible reassembly of HsaFtH. Diph nanoformulation was subsequently thoroughly characterized and tested for its non-target cytotoxicity and antiviral efficiency using a panel of pathogenic viral strain. Results: We revealed that loading into HsaFtH decreased the undesired cytotoxicity of Diph in mammalian host cells. We also confirmed that encapsulated Diph exhibited slightly lower antiviral activity than free Diph, which may be due to the differential uptake mechanism and kinetics of free Diph and Diph@HsaFtH. Furthermore, we confirmed that the antiviral effect was mediated solely by Diph with no contribution from HsaFtH. Conclusion: It was confirmed that HsaFtH is a suitable vehicle that allows easy loading of Diph and production of highly homogeneous nanoparticles dispersion with promising broad-spectrum antiviral activity. Keywords: drug delivery, SARS-CoV-2, TBEV, WNV, Zika virus Globalization, global climate change, and our way of life all increase the possibility of viral epidemics or pandemic outbreaks, such as the Spanish flu in 1918–1919, Zika in 2015–2016, and more recently the COVID-19 pandemic, which is estimated to have caused more than 6.7 million deaths. 1 Despite this, the development of efficient broad-spectrum antiviral agents remains a major challenge for the scientific community. Currently, no broad-spectrum antivirals are available; however, a plethora of antiviral drugs is routinely used to treat a variety of viral infections. Among them, remdesivir, oseltamivir, zalcitabine, ritonavir, acyclovir and others might be mentioned. 2 Unfortunately, it should be noted that these drugs are frequently characterized by poor bioavailability, low solubility, poor permeability, short half-life, and side effects that hinder their efficient utilization. 3 Therefore, stimulated by worldwide needs due to the ongoing COVID-19 pandemic, a plethora of de novo synthesized compounds or compounds isolated from various natural sources have been tested as potential novel antiviral compounds. Among them, diphyllin (Diph), a natural compound of the arylnaphthalide lignin family, seems to be a promising broad-spectrum antiviral candidate. 4,5 Diph [1-hydroxy-2-(hydroxymethyl)-6,7-dimethoxy-4-(3,4-methylenedioxy-phenol)-3-naphthoic acid-γ-lactone] and its derivatives have initially been shown to inhibit V-ATPase activity in human osteoclasts. 6 V-ATPases are proton pumps that acidify the endosomal lumen. 7 It is noteworthy that acidic endosomal pH is a crucial prerequisite for fusion o -Abstract Truncated-

Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses

Nanoformulation of the Broad-Spectrum Hydrophobic Antiviral Vacuolar ATPase Inhibitor Diphyllin in Human Recombinant H-ferritin

Evaluation of Potency and Metabolic Stability of Diphyllin-derived Vacuolar-ATPase Inhibitors

Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin

Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus

Antiviral activity of the host defense peptide piscidin 1: investigating a membrane-mediated mode of action

Discovery of Novel Pyridine-Dimethyl-Phenyl-DAPY Hybrids by Molecular Fusing of Methyl-Pyrimidine-DAPYs and Difluoro-Pyridinyl-DAPYs: Improving the Druggability toward High Inhibitory Activity, Solubility, Safety, and PK

Discovery of Peptidomimetic Spiropyrrolidine Derivatives As Novel 3clpro Inhibitors Against SARS-CoV-2

Synthesis and Preliminary Anticancer Evaluation of 4‐C Derivatives of Diphyllin

Synthesis and anti-tumor activity of nitrogen-containing derivatives of the natural product diphyllin

Optimization of the Antiviral Potency and Lipophilicity of Halogenated 2,6‐diarylpyridinamines As a Novel Class of HIV‐1 NNRTIS

A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex

Discovery, Optimization and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors.

Alkylated porphyrins have broad antiviral activity against hepadnaviruses, flaviviruses, filoviruses, and arenaviruses.

Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo

Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides

Improving the Anti-Hiv-1 Activity and Solubility of Poorly Water-Soluble DAPYs by Heteroaromatic Replacement Strategy: from Naphthalene-Dapys to Quinoline-Dapys.

Polyanionic Amphiphilic Dendritic Polyglycerols as Broad-Spectrum Viral Inhibitors with a Virucidal Mechanism

Discovery of Novel α-Aminophosphonates with Hydrazone as Potential Antiviral Agents Combined With Active Fragment and Molecular Docking

Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents

Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection